Monitor for any reverse stock split announcement or other compliance plan within the 180-day window, as well as further activist engagement from Glenbrook Capital. The preliminary revenue beat provides a fundamental narrative, but the stock must trade above $1.00 to avoid eventual delisting.
Price Chart
Executive Summary
SenesTech disclosed a Nasdaq deficiency notice for failing to maintain a $1.00 minimum bid price, with a 180-day cure period through April 19, 2027. The company reported preliminary Q3 2026 revenue of ~$1.1M (up 55% YoY and 40% sequentially), its highest ever, and noted activist Glenbrook Capital's 38% stake and cooperative stance. The delisting risk is material but the strong revenue growth and activist presence provide a counterbalance.
Key Financial Metrics
Key Facts
- Received Nasdaq deficiency notice on Oct. 20, 2026 for bid price below $1.00 for 30 consecutive business days
- Has 180 calendar days (until April 19, 2027) to regain compliance
- Preliminary Q3 2026 revenue of approximately $1.1 million, highest in company history
- Revenue up 55% year-over-year and 40% sequentially from Q2 2026
- Activist Glenbrook Capital holds 38.04% stake and has offered to cooperate with board/management
- Company evaluating financing alternatives and other options to regain compliance
Financial Impact
Preliminary Q3 revenue ~$1.1M, up 55% YoY; delisting risk with 180-day cure period; activist holds 38% stake
Risk Factors
- Failure to regain Nasdaq compliance could lead to delisting and reduced liquidity
- Potential dilutive financing to boost share price or fund operations
- Revenue growth must be sustained to support share price recovery
- Activist may push for board changes or strategic alternatives if progress stalls
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3386752 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | SC 13D | $0.8477 | awaiting T+5 | — | $0.8370 (−1.26%) |
Oct 22, 2026 5d ago | SC 13D/A | $0.8400 | awaiting T+5 | — | $0.8370 (−0.36%) |
Oct 22, 2026 5d ago | 8-K | $0.7990 | awaiting T+5 | — | $0.8370 (−4.76%) |
Oct 22, 2026 5d ago | Press Release | $0.7990 | awaiting T+5 | — | $0.8370 (+4.76%) |
Oct 19, 2026 8d ago | SC 13D/A | $0.6893 $0.8370 | ▲ +21.43% | ▲ +21.35% | $0.8370 (+21.43%) |
Oct 19, 2026 8d ago | Press Release | $0.7000 $0.8065 | ▲ +15.21% | ▲ +15.36% | $0.8370 (+19.57%) |
Oct 15, 2026 12d ago | 8-K | $0.6992 $0.7990 | ▲ +14.27% | ▲ +15.29% | $0.8370 (+19.71%) |
Oct 15, 2026 12d ago | Press Release | $0.6992 $0.7990 | ▲ +14.27% | ▲ +15.29% | $0.8370 (+19.71%) |
Aug 3, 2026 12w ago | 8-K | $1.55 $1.27 | ▼ −18.06% | ▼ −20.09% | $0.8370 (−46.00%) |
Jun 9, 2026 20w ago | Insider Cluster | $1.72 $1.65 | ▼ −4.07% | ▼ −7.50% | $0.8370 (−51.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers